Friday, July 10, 2026

Drug profile · INN

valganciclovir

valganciclovir (VALCYTE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved NMPA: clinical trials
Patents linked 1
Pipeline programs 2
News articles 0
Drug details — valganciclovir

Quick answer

valganciclovir (VALCYTE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN valganciclovir
Brand VALCYTE

Approval history

Authority Status Date
TGA approved
NMPA clinical trials

Pipeline programs

  1. APHP220791 Phase 3 · PARItec · CytoMegaloVirus infections, Kidney transplant
  2. Protocol number 8 Phase 2 · George Institute for · Glioblstoma WHO grade IV
  1. AU 2007332640

    Powder formulation for valganciclovir

    Expires Wed Jun 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is valganciclovir?

valganciclovir (VALCYTE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for valganciclovir?

VALCYTE is a marketed brand name for valganciclovir. Check FDA Drugs@FDA for the current US label holder and prescribing information.